A skin fungus turns out to be an ally

Malassezia is the most abundant fungal coloniser of mammalian skin. In medicine it usually appears as the culprit: tinea versicolor, seborrhoeic dermatitis, flares of atopic dermatitis. A paper in Nature Microbiology shows the other side of that relationship and describes a mechanism by which the same fungus supports the normal working of the epidermis.

The key lies in metabolites derived from tryptophan. The authors showed that derivatives produced by Malassezia furfur activate the aryl hydrocarbon receptor, AhR, which regulates keratinocyte differentiation and inflammation. In human epidermal equivalents that activation was measurable, and in mouse epidermis it increased proteins important for skin structure and barrier function.

Causation was tested from both sides, and that is the strongest part of the work. In a mouse model of atopic dermatitis, colonisation by M. furfur with tryptophan supplementation reduced inflammation and restored barrier function — but a fungal mutant unable to produce indoles did not. Conversely, mice lacking AhR specifically in keratinocytes gained no benefit from the fungus. The effect depends on both the molecule and the receptor.

The general conclusion reaches beyond dermatology. Dividing microorganisms into "good" and "pathogenic" is of little use for the skin microbiota: the same species can be either, depending on the state of the barrier, the supply of substrate and the host's genetics. It is the same pattern seen in gut yeasts and in many soil fungi.

The limits of interpretation: this was done in a mouse model and in epidermal equivalents, not in a clinical trial. The result does not justify taking tryptophan supplements or changing how atopic dermatitis is managed.

It is worth recalling what Malassezia is. These are lipophilic yeasts — they need fats to grow and cannot make their own, so they live where the skin secretes them: the scalp, the face, the back. That dependence explains why dandruff worsens in periods of increased sebaceous activity, and why anti-dandruff preparations act on the symptom rather than on the fungus's presence.

The new result shifts the centre of gravity in thinking about treatment. If the same species can support the epidermal barrier, then "eliminate the fungus" is a worse-posed goal than "restore the conditions under which its presence is beneficial". The analogy with the gut microbiota suggests itself, and is, like every analogy, useful for asking questions rather than drawing conclusions.

What the study does not say should be stated plainly. It names no preparation, compares no diets and does not suggest that eating tryptophan-rich food will affect the skin — the metabolite's route here runs through a fungus on the epidermis, not through the gut.

Evidence status — 29 August 2026

The peer-reviewed article was published on 19 June 2026. In culture and in mice, Malassezia furfur produced tryptophan metabolites that activated the AhR receptor and supported epidermal-barrier homeostasis. This establishes a commensal function for a particular strain in a particular model; it does not show that every Malassezia is always beneficial, that the effect is identical on human skin, or that applying the yeast treats tinea versicolor. The study matters because a microorganism best known from disease can have a protective function in another context. Human-skin studies and separation of the effects of individual metabolites are the next necessary steps.